Hydralazine-induced antineutrophil cytoplasmic antibody vasculitis with significant dermatologic manifestations. [PDF]
Patel A +4 more
europepmc +1 more source
Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis. [PDF]
Han XY +5 more
europepmc +1 more source
Association Between Severe Kidney Impairment at Treatment Initiation and Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis. [PDF]
Onogi C +4 more
europepmc +1 more source
Antineutrophil cytoplasmic antibody-associated pachymeningitis: a systematic review of clinical features, diagnosis and treatment outcomes. [PDF]
Faria GAS +6 more
europepmc +1 more source
Validation study of the antineutrophil cytoplasmic antibody (ANCA) kidney risk score in Japanese patients with ANCA-associated glomerulonephritis. [PDF]
Yamashita A +12 more
europepmc +1 more source
Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). [PDF]
Juto A +7 more
europepmc +1 more source
Therapeutic Dilemmas in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Diffuse Alveolar Hemorrhage and Venous Thromboembolism. [PDF]
Ediboglu ED +5 more
europepmc +1 more source
Immunoglobulin replacement therapy in antineutrophil cytoplasmic antibody-associated vasculitis with rituximab-associated hypogammaglobulinemia: infection outcomes and disease course in a retrospective cohort. [PDF]
Gross M +4 more
europepmc +1 more source
Non-suppurative Destructive Cholangitis After Avacopan Therapy in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (MPO-ANCA)-Associated Glomerulonephritis: A Case Report and Review of the Literature. [PDF]
Terakawa K +15 more
europepmc +1 more source
From Pulmonary Tuberculosis to Antineutrophil Cytoplasmic Antibody (ANCA) Seroconversion: A Case of Rapidly Progressive Glomerulonephritis. [PDF]
AlShammari OA +11 more
europepmc +1 more source

